🇺🇸 FDA
Pipeline program

1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative

LTao-EC IIa

Phase 2 mab completed

Quick answer

1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative for Tuberculosis is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Tuberculosis
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials